Increased C-reactive protein concentration was evident in most patients (236/291, 81.1%), but it was more likely to be increased in influenza A patients (93.8%) than in COVID-19 patients (68.3%) (OR 0.1, 95% CI 0.0–0.3). The gene discussed is CRP; the disease is COVID-19.